Patent · US Expired

3,4-dihydro-benzo[e][1,3]oxazin-2-ones

US7795251B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Andreas Billich · Wien, AT
Hubert Gstach · Wien, AT
Philipp Lehr · Spittal an der Drau, AT

Key dates

Filing date	Apr 13, 2006
Grant date	Sep 14, 2010
Priority date	—
Expiry date	May 5, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates 3,4-dihydro-benzo[e][1,3]oxazin-2-ones which are substituted at the nitrogen atom by unsubstituted or substituted (C1-8)alkyl, (C3-8)cycloalkyl, (C3-8)cycloalkyl(C1-4)alkyl, (C6-18)aryl or (C6-18)aryl(C1-4)alkyl and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.